$486,406 small biz innovation grant for Storrs’ Biorasis

Storrs-based Biorasis Inc. has secured a $486,406 Small Business Innovation Research Phase II grant from the National Science Foundation which it will use to develop a wireless, self-calibrating, needle implantable miniaturized sensor for continuous glucose monitoring for diabetics, potentially eliminating the need for frequent, external finger-pricking. The agreement reauthorized the program for six years, increasing Phase I award levels from $100,000 to $150,000 and increasing Phase II award levels from $750,000 to $1 million.